Rheumatic Disease Awareness Month: Focus on Obesity and Inflammation
When it comes to inflammatory pathogenesis, obesity and rheumatic and musculoskeletal diseases share common features.
Reference1. Nikiphorou E, Fragoulis GE. Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review. Ther Adv Musculoskelet Dis. 2018;10:157-167. doi: 10.1177/1759720X18783894.
Nikiphorou and Fragoulis, researchers in the UK, look at common pathways for inflammation in obesity and rheumatic and musculoskeletal diseases.1 Scroll through the slides for the details of their review and the take-home points for physicians.
(Image: ©alphaspirit/Shutterstock.com)
Bregs, B-regulatory cells; RMD, rheumatic and musculoskeletal disease.
AS, ankylosing spondylitis; BMI, body mass index; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.
RA, rheumatoid arthritis.
PsA, psoriatic arthritis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.
AS, ankylosing spondylitis; RA, rheumatoid arthritis.
RA, rheumatoid arthritis.
BMI, body mass index; EULAR, European League Against Rheumatism; PsA, psoriatic arthritis; SpA, spondyloarthritis; TNF, tumor necrosis factor.
AS, ankylosing spondylitis; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; TNF, tumor necrosis factor.
BMI, body mass index; SLE, systemic lupus erythematosus.
RA, rheumatoid arthritis; RMD, rheumatic and musculoskeletal disease.
